Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Medifast Q1 EPS $(0.07) Beats $(0.27) Estimate, Sales $115.73M Beat $110.10M Estimate

Author: Benzinga Newsdesk | April 28, 2025 03:11pm
Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.27) by 74.07 percent. This is a 110.61 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $115.73 million which beat the analyst consensus estimate of $110.10 million by 5.11 percent. This is a 33.77 percent decrease over sales of $174.74 million the same period last year.

Posted In: MED

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist